Luliconazole API had shifting market patterns in the North American region during the fourth quarter of 2022. Beginning with Q4 2022, prices were predicted to rise through the second month of the quarter due to a high cost of manufacturing, numerous logistical problems, and rising inflation. Additionally, the market position was maintained well by rising transportation costs and port congestion at the major ports. Prices begin to decline later in December because of softening inflation and declining end-user sector demand. During the month of December, the settlement price of Luliconazole API came down to USD 463500/MT CFR in New York.
In the fourth quarter of 2022, the Luliconazole Prices witnessed fluctuating trajectory in the Asia Pacific region. At the commencement of Q4 2022, the prices were recorded to increase till the second month of Q4 on the back of increasing demand from the end-user sector and several logistic issues. Also, the strict zero covid policies and repeated lockdowns in the Chinese provinces affected the market situation. The increased production cost on the back of rising energy prices and increased domestic manufacturing to cater to regional and international orders kept the market tight. However, later in the month of December, the prices of Luliconazole API went down as the domestic merchants had enough inventories on their shelves. During the month of December, the settlement price of Luliconazole API came down to USD 390050/MT FOB Shanghai.
In the Fourth quarter of 2022, the prices of Luliconazole API showcased a see-saw trajectory in the European region. The downstream pharmaceutical sector's demand for Luliconazole API was recorded to be consistent. However, the ongoing port congestion and supply disruption in the European region affected the supply chain and compelled the prices to increase in the first two months of Q4 2022. Also, the high freight charges contributed to the hiked-up trajectory of Luliconazole API. Nevertheless, the prices drop in the month of December owing to existing inventories and lowering demand from the end-user sector. During the month of December, the settlement price of Luliconazole API came down to USD 429000/MT CFR Hamburg.
ChemAnalyst addresses the vital problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make intelligent choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls efficiently and agilely. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic and global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.